📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Characterization of TAE684 as a potent LRRK2 kinase inhibitor. (2012)

First Author: Zhang J

Attributed to: A systematic investigation into the pathogenesis and course of Parkinson's syndrome funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.bmcl.2012.01.084

PubMed Identifier: 22335897

Publication URI: http://europepmc.org/abstract/MED/22335897

Type: Journal Article/Review

Volume: 22

Parent Publication: Bioorganic & medicinal chemistry letters

Issue: 5

ISSN: 0960-894X